Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Stolz, N. Smyrnios, P. Eggimann, H. Pargger, N. Thakkar, M. Siegemund, S. Marsch, J. Rakic, B. Müller, M. Tamm (Basel, Lausanne, Aarau, Switzerland; Worcester, United States Of America). Procalcitonin for antibiotic de-escalation in ventilator associated pneumonia – a randomised study. Eur Respir J 2009; 34: Suppl. 53, 2798

Member's Comments

No comment yet.

Related content which might interest you: Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Source: Eur Respir J 2009; 34: 1364-1375 Year: 2009 Effect of de-escalation antibiotic therapy on hospital-acquired, ventilator associated, and healthcare-associated pneumonia: A systematic review and meta-analysis Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Procalcitonin-guided antibiotic therapy in acute exacerbations of COPD (AECOPD): a randomised trial - The ProCOLD Study Source: Eur Respir J 2005; 26: Suppl. 49, 464s Year: 2005 Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study Source: Eur Respir J, 56 (4) 2001935; 10.1183/13993003.01935-2020 Year: 2020 Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment; results from the German competence network CAPNETZ Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Late Breaking Abstract - Effect of adjunctive tobramycin inhalation therapy in the treatment of ventilator-associated pneumonia: findings from the randomized VAPORISE trial Source: International Congress 2019 – Recent developments in intensive care unit medicine Year: 2019 Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial Source: Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020 Year: 2021 Nosocomial pneumonia and non invasive ventilation in a tertiary public hospital – an observational study Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure Year: 2009 Evaluation of moxifloxacin (MXF) as empiric antibiotic therapy of CAP outpatients: A multicenter prospective study Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis Source: Eur Respir Rev 2017; 26: 160073 Year: 2017 Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015 Optimising the duration of antibiotic therapy for ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 40-44 Year: 2007 A multicenter randomised controlled trial to evaluate continuous-positive airway pressure (CPAP) versus conventional oxygen in patients with acute respiratory failure (ARF) due to community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure Year: 2009 Point-of-care procalcitonin test to reduce antibiotics in COPD exacerbation: A quasi-randomised control trial Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives Source: Eur Respir J 2004; 24: Suppl. 48, 185s Year: 2004 Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Could procalcitonin (PCT) be a marker of effectiveness of antibiotic treatment (ABT) in pregnant with not severe community-acquired pneumonia (CAP)? Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Procalcitonin and neopterin in community-acquired pneumonia – correlation with microbial aetiology, severity and mortality Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis Source: Eur Respir J 2008; 31: 1068-1076 Year: 2008